ANDREW YEE to Clinical Trials as Topic
This is a "connection" page, showing publications ANDREW YEE has written about Clinical Trials as Topic.
Connection Strength
0.040
-
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide. Expert Rev Hematol. 2024 Aug; 17(8):445-465.
Score: 0.040